• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

夫马加隆,一种2型蛋氨酸氨基肽酶和血管生成的可逆抑制剂。

Fumagalone, a reversible inhibitor of type 2 methionine aminopeptidase and angiogenesis.

作者信息

Zhou Guochun, Tsai Chiawei W, Liu Jun O

机构信息

Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.

出版信息

J Med Chem. 2003 Jul 31;46(16):3452-4. doi: 10.1021/jm0341103.

DOI:10.1021/jm0341103
PMID:12877582
Abstract

Fumagillin and ovalicin constitute a family of structurally related natural products that possess antiangiogenic activity. We report the synthesis of a new fumagillin analogue, fumagalone, in which the spiroepoxide group is replaced with an aldehyde. Fumagalone inhibits type 2 methionine aminopeptidase (MetAP2) with IC(50) = 8 microM and endothelial cell proliferation with IC(50) = 52 nM. With dialysis and competition assays, it was unambiguously demonstrated that binding of fumagalone to MetAP2 is reversible.

摘要

烟曲霉素和椭圆玫瑰树碱构成了一类具有抗血管生成活性的结构相关天然产物。我们报道了一种新的烟曲霉素类似物烟曲醛的合成,其中螺环氧基团被醛基取代。烟曲醛抑制2型甲硫氨酸氨肽酶(MetAP2)的IC50为8微摩尔,抑制内皮细胞增殖的IC50为52纳摩尔。通过透析和竞争试验,明确证明了烟曲醛与MetAP2的结合是可逆的。

相似文献

1
Fumagalone, a reversible inhibitor of type 2 methionine aminopeptidase and angiogenesis.夫马加隆,一种2型蛋氨酸氨基肽酶和血管生成的可逆抑制剂。
J Med Chem. 2003 Jul 31;46(16):3452-4. doi: 10.1021/jm0341103.
2
Fumarranol, a rearranged fumagillin analogue that inhibits angiogenesis in vivo.富马瑞诺醇,一种重排的烟曲霉素类似物,可在体内抑制血管生成。
J Med Chem. 2006 Sep 21;49(19):5645-8. doi: 10.1021/jm060559v.
3
Enantioselective approaches to potential MetAP-2 reversible inhibitors.潜在甲硫氨酸氨肽酶-2可逆抑制剂的对映选择性方法。
J Org Chem. 2005 Mar 18;70(6):2409-12. doi: 10.1021/jo047858h.
4
Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2.甲硫氨酸氨肽酶2对血管生成抑制剂烟曲霉素和椭圆玫瑰树碱的分子识别
Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15183-8. doi: 10.1073/pnas.95.26.15183.
5
Selective inhibition of endothelial cell proliferation by fumagillin is not due to differential expression of methionine aminopeptidases.烟曲霉毒素对内皮细胞增殖的选择性抑制并非由于甲硫氨酸氨基肽酶的差异表达。
J Cell Biochem. 2000 Apr;77(3):465-73.
6
Syntheses of fumagillin and ovalicin.呋嘛精及卵形菌素的合成。
Chemistry. 2010 Apr 6;16(13):3884-901. doi: 10.1002/chem.200902433.
7
Design and synthesis of highly potent fumagillin analogues from homology modeling for a human MetAP-2.基于人源甲硫氨酸氨肽酶-2的同源建模设计与合成高效烟曲霉素类似物。
Bioorg Med Chem Lett. 2000 Jan 3;10(1):39-43. doi: 10.1016/s0960-894x(99)00577-6.
8
Carbamate analogues of fumagillin as potent, targeted inhibitors of methionine aminopeptidase-2.作为一种强效的、有针对性的蛋氨酸氨肽酶-2抑制剂,福米胍的氨基甲酸酯类似物。
J Med Chem. 2009 Dec 24;52(24):8047-56. doi: 10.1021/jm901260k.
9
Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin.蛋氨酸氨基肽酶2型是血管生成抑制剂AGM - 1470和卵霉素的共同作用靶点。
Chem Biol. 1997 Jun;4(6):461-71. doi: 10.1016/s1074-5521(97)90198-8.
10
Synthesis and biological evaluation of novel fumagillin and ovalicin analogues.新型烟曲霉素和卵霉素类似物的合成及生物学评价
Org Biomol Chem. 2005 Jun 7;3(11):2150-4. doi: 10.1039/b503163j. Epub 2005 Apr 22.

引用本文的文献

1
Orally active fumagillin analogues: transformations of a reactive warhead in the gastric environment.口服活性烟曲霉素类似物:反应弹头在胃部环境中的转化
ACS Med Chem Lett. 2013 Feb 22;4(4):381-6. doi: 10.1021/ml3003633. eCollection 2013 Apr 11.
2
System for expression of microsporidian methionine amino peptidase type 2 (MetAP2) in the yeast Saccharomyces cerevisiae.用于在酿酒酵母中表达微小孢子虫蛋氨酸氨基肽酶2(MetAP2)的系统。
Antimicrob Agents Chemother. 2006 Oct;50(10):3389-95. doi: 10.1128/AAC.00726-06. Epub 2006 Aug 17.
3
Structure of the angiogenesis inhibitor ovalicin bound to its noncognate target, human Type 1 methionine aminopeptidase.
血管生成抑制剂卵霉素与其非同源靶标人1型甲硫氨酸氨基肽酶结合的结构。
Protein Sci. 2006 Aug;15(8):1842-8. doi: 10.1110/ps.062278006. Epub 2006 Jul 5.